Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease
Autophagy has been shown to play an important role in Parkinson’s disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson’s disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture mediu...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eb2331ff0b84061875ba3822553891b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4eb2331ff0b84061875ba3822553891b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4eb2331ff0b84061875ba3822553891b2021-11-19T12:16:44ZSchwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease1673-537410.4103/1673-5374.327353https://doaj.org/article/4eb2331ff0b84061875ba3822553891b2022-01-01T00:00:00Zhttp://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=6;spage=1357;epage=1363;aulast=Yanhttps://doaj.org/toc/1673-5374Autophagy has been shown to play an important role in Parkinson’s disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson’s disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture medium containing skin-derived precursors differentiated into Schwann cells (SKP-SCs). The results showed that the SKP-SC culture medium remarkably enhanced the activity of SH-SY5Y cells damaged by 6-hydroxydopamine, reduced excessive autophagy, increased tyrosine hydroxylase expression, reduced α-synuclein expression, reduced the autophagosome number, and activated the PI3K/AKT/mTOR pathway. Autophagy activator rapamycin inhibited the effects of SKP-SCs, and autophagy inhibitor 3-methyladenine had the opposite effect. These findings confirm that SKP-SCs modulate the PI3K/AKT/mTOR pathway to inhibit autophagy, thereby exhibiting a neuroprotective effect in a cellular model of Parkinson’s disease. This study was approved by the Animal Ethics Committee of Laboratory Animal Center of Nantong University (approval No. S20181009-205) on October 9, 2018.Jia-Nan YanHai-Ying ZhangJun-Rui LiYing ChenYong-Cheng JiangJia-Bing ShenKai-Fu KeXiao-Su GuWolters Kluwer Medknow Publicationsarticlealpha-synuclein; autophagosomes; autophagy; neural regeneration; neuroprotection; parkinson′s disease; pi3k/akt/mtor pathway; skin-derived precursor schwann cellsNeurology. Diseases of the nervous systemRC346-429ENNeural Regeneration Research, Vol 17, Iss 6, Pp 1357-1363 (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
alpha-synuclein; autophagosomes; autophagy; neural regeneration; neuroprotection; parkinson′s disease; pi3k/akt/mtor pathway; skin-derived precursor schwann cells Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
alpha-synuclein; autophagosomes; autophagy; neural regeneration; neuroprotection; parkinson′s disease; pi3k/akt/mtor pathway; skin-derived precursor schwann cells Neurology. Diseases of the nervous system RC346-429 Jia-Nan Yan Hai-Ying Zhang Jun-Rui Li Ying Chen Yong-Cheng Jiang Jia-Bing Shen Kai-Fu Ke Xiao-Su Gu Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease |
description |
Autophagy has been shown to play an important role in Parkinson’s disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson’s disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture medium containing skin-derived precursors differentiated into Schwann cells (SKP-SCs). The results showed that the SKP-SC culture medium remarkably enhanced the activity of SH-SY5Y cells damaged by 6-hydroxydopamine, reduced excessive autophagy, increased tyrosine hydroxylase expression, reduced α-synuclein expression, reduced the autophagosome number, and activated the PI3K/AKT/mTOR pathway. Autophagy activator rapamycin inhibited the effects of SKP-SCs, and autophagy inhibitor 3-methyladenine had the opposite effect. These findings confirm that SKP-SCs modulate the PI3K/AKT/mTOR pathway to inhibit autophagy, thereby exhibiting a neuroprotective effect in a cellular model of Parkinson’s disease. This study was approved by the Animal Ethics Committee of Laboratory Animal Center of Nantong University (approval No. S20181009-205) on October 9, 2018. |
format |
article |
author |
Jia-Nan Yan Hai-Ying Zhang Jun-Rui Li Ying Chen Yong-Cheng Jiang Jia-Bing Shen Kai-Fu Ke Xiao-Su Gu |
author_facet |
Jia-Nan Yan Hai-Ying Zhang Jun-Rui Li Ying Chen Yong-Cheng Jiang Jia-Bing Shen Kai-Fu Ke Xiao-Su Gu |
author_sort |
Jia-Nan Yan |
title |
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease |
title_short |
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease |
title_full |
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease |
title_fullStr |
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease |
title_full_unstemmed |
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease |
title_sort |
schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of parkinson’s disease |
publisher |
Wolters Kluwer Medknow Publications |
publishDate |
2022 |
url |
https://doaj.org/article/4eb2331ff0b84061875ba3822553891b |
work_keys_str_mv |
AT jiananyan schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease AT haiyingzhang schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease AT junruili schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease AT yingchen schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease AT yongchengjiang schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease AT jiabingshen schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease AT kaifuke schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease AT xiaosugu schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease |
_version_ |
1718420069020598272 |